skip to main content
Idioma:
Refinado por: Nome da Publicação: Journal Of Clinical Psychopharmacology remover assunto: Science & Technology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine
Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetic and pharmacodynamic evaluation of the inhibition of alprazolam by citalopram and fluoxetine

HALL, Judith ; NARANJO, Claudio A ; SPROULE, Beth A ; HERRMANN, Nathan

Journal of clinical psychopharmacology, 2003-08, Vol.23 (4), p.349-357 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
2
Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers
Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Paroxetine steady-state plasma concentration in relation to CYP2D6 genotype in extensive metabolizers

Ozdemir, V ; Tyndale, R F ; Reed, K ; Herrmann, N ; Sellers, E M ; Kalow, W ; Naranjo, C A

Journal of clinical psychopharmacology, 1999-10, Vol.19 (5), p.472-475 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Dose-response evaluation of the interaction between sertraline and alprazolam in vivo
Dose-response evaluation of the interaction between sertraline and alprazolam in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose-response evaluation of the interaction between sertraline and alprazolam in vivo

HASSAN, P. C ; SPROULE, B. A ; NARANJO, C. A ; HERRMANN, N

Journal of clinical psychopharmacology, 2000-04, Vol.20 (2), p.150-158 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
4
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline
Material Type:
Artigo 		Adicionar ao Meu Espaço

The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline

ÖZDEMIR, V ; NARANJO, C. A ; HERRMANN, N ; SHULMAN, R. W ; SELLERS, E. M ; REED, K ; KALOW, W

Journal of clinical psychopharmacology, 1998-02, Vol.18 (1), p.55-61 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
5
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo

ÖZDEMIR, V ; NARANJO, C. A ; SHULMAN, R. W ; HERRMANN, N ; SELLERS, E. M ; REED, K ; KALOW, W

Journal of clinical psychopharmacology, 1998-06, Vol.18 (3), p.198-207 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.